Target intelligence / Profile preview

PDZ and LIM domain 1 pseudogene 4 (PDLIM1P4)

Target: PDLIM1P4
Molecular classification: Other (Pseudogene)

Overview

PDZ and LIM domain 1 pseudogene 4 (PDLIM1P4) is classified as a pseudogene—a non-functional segment of DNA that resembles the functional PDZ and LIM domain 1 gene but is unable to produce a functional protein product[2][3]. Pseudogenes like PDLIM1P4 do not participate directly in cellular signaling, metabolism, or other canonical biological functions as protein-coding genes do. However, PDLIM1P4 expression may be associated with malignancy or disease progression and can serve as a biomarker, for example, in multiple myeloma, where upregulation correlates with worse patient outcomes[1]. There is no evidence that PDLIM1P4 encodes a functional receptor, enzyme, or drug target, nor any indication of interacting drugs or known mechanisms of action.

Other names: PDZ and LIM domain 1 pseudogene 4PDLIM1P4

Disease associations

Some studies list upregulation of PDLIM1P4 association with worse progression-free survival (PFS) and overall survival (OS) in multiple myeloma, indicating possible utility in cancer biology as a non-coding RNA biomarker rather than a therapeutic target[1].

Biomarkers

Possible biomarker for cancer progression (based on expression studies in multiple myeloma; high expression associated with worse PFS and OS)[1].

Beyond the preview

Go deeper on PDZ and LIM domain 1 pseudogene 4 (PDLIM1P4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PDZ and LIM domain 1 pseudogene 4 (PDLIM1P4).

Explore the full profile